Linked Life Data

2689506

Source:http://linkedlifedata.com/resource/pubmed/id/2689506

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1990-2-2
pubmed:abstractText
Oral, double-blind administration in 2 groups of 20 patients each of a placebo versus 100mg Mifepriston given morning and evening for 48 hours, shows that this progesterone antagonist exerts a softening and dilating effect on the uterine cervix. This effect facilitates the instrumental dilation required for termination of pregnancy on the first trimester. While effective and free of side effects, this technic for cervical preparation has the further advantage of being nearly painless and thus may be applied to out-patients.
pubmed:language
fre
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0368-2315
pubmed:author
pubmed:issnType
Print
pubmed:volume
18
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
801-8
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:year
1989
pubmed:articleTitle
[Oral administration of an antiprogesterone (Mifepristone, RU 486) for preparing the cervix uteri for pregnancy interruption during the first trimester].
pubmed:affiliation
Département de gynécologie-obstétrique, C.H.U. Vandois, Lausanne.
pubmed:publicationType
Journal Article, Clinical Trial, English Abstract, Randomized Controlled Trial